Xiang Xu
17PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|Nov 18, 2025
Mesenchymal stem cells combined with IFN-γ treatment versus mesenchymal stem cells monotherapy: safety and efficacy over five years extension follow-up.Yi Yang, Xiao He, Mengwei Yao
|May 21, 2025
Gene therapy prevents onset of mitochondrial cardiomyopathy in neonatal mice with Ndufs6 deficiency.Xiaoxian Zhang, Li Huang, Cheng Li
|Apr 06, 2024
The dual role of mesenchymal stem cells in apoptosis regulation.Zhuo Chen, Xuewei Xia, Mengwei Yao
|Apr 02, 2024
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.Qiu-Zhong Pan, Jing-Jing Zhao, Liang Liu
|Sep 21, 2023
The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer.Xiaohui Wang, Wei Qiu, Haoyu Liu
|Feb 16, 2023
Fibulin2: a negative regulator of BMSC osteogenic differentiation in infected bone fracture healing.Shi-Dan Li, Wei Xing, Shao-Chuan Wang
Pageof 3
